Why This Account Matters: RMG is in the midst of its most ambitious technology and operational transformation in its 50-year history. A newly appointed CTO (ex-Accenture, ex-Deloitte) with an explicit AI and digital transformation mandate, three China hospitals scaling simultaneously, a new longevity platform launching, a precision oncology partnership signed, and a share buyback programme — all signal an organisation building the institutional infrastructure to support its next decade of growth. This convergence of mandates across technology, clinical systems, China expansion, and preventive health creates multiple simultaneous entry points for the right enterprise vendor.